Neuralink has dominated the brain-chip story for two years. It now has a serious challenger with a patient of its own. Paradromics, an Austin neurotech firm, has implanted its Connexus brain-computer interface in the first participant of its FDA-approved clinical study, the company said.

Source: [TNW](https://thenextweb.com/news/paradromics-first-clinical-brain-chip-implant-speech)

Sponsored